Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Comparative neuropharmacology of antianxiety drugs
Steven M. Paul
, Phil Skolnick
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
27
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Comparative neuropharmacology of antianxiety drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Neuropharmacology
100%
Anxiolytic
100%
Benzodiazepine Receptor
100%
Ionophore
100%
Receptor
100%
Gamma-Aminobutyric Acid
50%
Neurotransmitter
50%
Barbiturate
50%
Benzodiazepine
50%
GABA Receptor
50%
Chloride Channel
50%
Behavioral Effect
50%
Receptor Affinity
50%
Chloride
50%
Buspirone
50%
Keyphrases
Neuropharmacology
100%
Anti-anxiety
100%
Mechanism of Action
66%
Benzodiazepines
66%
Benzodiazepine Receptor
66%
Chloride Ionophore
66%
GABAA Receptor (GABAAR)
33%
Inhibitory Neurotransmitter
33%
Anxiolytic Activity
33%
Tranquilizers
33%
Barbiturates
33%
Buspirone
33%
Chloride Channel
33%
Receptor Complex
33%
High-affinity Receptor
33%
Behavioral Effects
33%
Novel Anxiolytics
33%
Triazolopyridazine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Neuropharmacology
100%
Anxiolytic
66%
Benzodiazepine Receptor
66%
Ionophore
66%
4 Aminobutyric Acid
33%
Neurotransmitter
33%
Barbiturate
33%
Benzodiazepine
33%
Buspirone
33%
Chloride Channel
33%
Behavioral Effect
33%
4 Aminobutyric Acid Receptor
33%
Chloride
33%